What is he best known for?
The fields of study he is best known for:
Liewei Wang focuses on Pharmacogenomics, Genetics, Single-nucleotide polymorphism, Pharmacogenetics and Bioinformatics.
His research integrates issues of Drug response and Drug in his study of Pharmacogenomics.
Liewei Wang regularly ties together related areas like Computational biology in his Genetics studies.
Liewei Wang studied Single-nucleotide polymorphism and Molecular biology that intersect with MDC1, Exon, DNA damage, Gene and DNA repair.
His work in Pharmacogenetics covers topics such as Thiopurine methyltransferase which are related to areas like Allele and Biochemistry.
His Bioinformatics research includes themes of Proportional hazards model and Disease.
His most cited work include:
- Genomics and Drug Response (463 citations)
- FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. (461 citations)
- ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. (325 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cancer research, Internal medicine, Pharmacogenomics, Single-nucleotide polymorphism and Breast cancer.
His study focuses on the intersection of Cancer research and fields such as Protein kinase B with connections in the field of PI3K/AKT/mTOR pathway.
His Internal medicine research incorporates elements of Endocrinology and Oncology.
While the research belongs to areas of Pharmacogenomics, Liewei Wang spends his time largely on the problem of Pharmacogenetics, intersecting his research to questions surrounding Thiopurine methyltransferase.
His work on Molecular biology expands to the thematically related Single-nucleotide polymorphism.
His study looks at the relationship between Gene and fields such as Computational biology, as well as how they intersect with chemical problems.
He most often published in these fields:
- Cancer research (25.75%)
- Internal medicine (25.42%)
- Pharmacogenomics (21.74%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (25.75%)
- Internal medicine (25.42%)
- Breast cancer (20.40%)
In recent papers he was focusing on the following fields of study:
Liewei Wang spends much of his time researching Cancer research, Internal medicine, Breast cancer, Pharmacogenomics and Oncology.
His work carried out in the field of Cancer research brings together such families of science as Cancer, Lung cancer, Androgen receptor and Tyrosine phosphorylation.
His Internal medicine research is multidisciplinary, relying on both Major depressive disorder and Depression.
His Pharmacogenomics study is related to the wider topic of Bioinformatics.
Within one scientific family, Liewei Wang focuses on topics pertaining to Precision medicine under Bioinformatics, and may sometimes address concerns connected to Genome-wide association study.
Liewei Wang focuses mostly in the field of Oncology, narrowing it down to topics relating to Letrozole and, in certain cases, Exemestane.
Between 2019 and 2021, his most popular works were:
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial (43 citations)
- Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases. (20 citations)
- Knowledge-guided analysis of "omics" data using the KnowEnG cloud platform. (14 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Pharmacogenomics, Internal medicine, Genomics, CYP2C19 and Cell biology.
His Pharmacogenomics research is multidisciplinary, incorporating elements of Intensive care medicine, Economic evaluation, Disease management, Disease and VKORC1.
His research is interdisciplinary, bridging the disciplines of Oncology and Internal medicine.
Liewei Wang interconnects Data integration, Multi omics, Combination therapy, Computational biology and Omics in the investigation of issues within Genomics.
His research investigates the link between CYP2C19 and topics such as Serotonin transport that cross with problems in Major depressive disorder, Citalopram and Escitalopram.
The various areas that Liewei Wang examines in his Cell biology study include Histone H4, DNA ligase and SUV39H1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
